Novo Nordisk A/S Announces Availability of Disclosure on Executive Share Transactions

Reuters
2025.08.08 13:52
portai
I'm PortAI, I can summarize articles.

Novo Nordisk A/S has disclosed the sale of 28,710 shares by Executive Vice President Ludovic Helfgott at a price of DKK 295.00 per share, totaling DKK 8,469,450.00. The transaction occurred on August 7, 2025, at Nasdaq Copenhagen. For further details, visit novonordisk.com. This information was published via EDGAR by Novo Nordisk A/S on August 08, 2025.

Novo Nordisk A/S has published a disclosure regarding the sale of shares by Ludovic Helfgott, an Executive Vice President at the company. The transaction involved the sale of 28,710 shares at a price of DKK 295.00 per share, totaling DKK 8,469,450.00. The transaction took place on August 7, 2025, at Nasdaq Copenhagen. For more information, visit novonordisk.com (here). Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Novo Nordisk A/S published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001171843-25-005210), on August 08, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.